vs
Side-by-side financial comparison of DULUTH HOLDINGS INC. (DLTH) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
DULUTH HOLDINGS INC. is the larger business by last-quarter revenue ($114.9M vs $85.1M, roughly 1.3× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -8.8%, a 31.6% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -9.6%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-8.9M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -31.6%).
Duluth Holdings Inc., which primarily sells goods through its Duluth Trading Company brand, is an American workwear and accessories company.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
DLTH vs FDMT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $114.9M | $85.1M |
| Net Profit | $-10.1M | $19.4M |
| Gross Margin | 53.8% | — |
| Operating Margin | -7.7% | 17.3% |
| Net Margin | -8.8% | 22.8% |
| Revenue YoY | -9.6% | 8508900.0% |
| Net Profit YoY | 64.6% | 139.1% |
| EPS (diluted) | $-0.29 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $114.9M | $85.1M | ||
| Q3 25 | $131.7M | $90.0K | ||
| Q2 25 | $102.7M | $15.0K | ||
| Q1 25 | $241.3M | $14.0K | ||
| Q4 24 | $127.1M | $1.0K | ||
| Q3 24 | $141.6M | $3.0K | ||
| Q2 24 | $116.7M | $5.0K | ||
| Q1 24 | $245.6M | $28.0K |
| Q4 25 | $-10.1M | $19.4M | ||
| Q3 25 | $1.3M | $-56.9M | ||
| Q2 25 | $-15.3M | $-54.7M | ||
| Q1 25 | $-5.6M | $-48.0M | ||
| Q4 24 | $-28.2M | — | ||
| Q3 24 | $-2.0M | $-43.8M | ||
| Q2 24 | $-7.9M | $-35.0M | ||
| Q1 24 | $6.4M | $-32.4M |
| Q4 25 | 53.8% | — | ||
| Q3 25 | 54.7% | — | ||
| Q2 25 | 52.0% | — | ||
| Q1 25 | 44.1% | — | ||
| Q4 24 | 52.3% | — | ||
| Q3 24 | 52.3% | — | ||
| Q2 24 | 52.8% | — | ||
| Q1 24 | 48.2% | — |
| Q4 25 | -7.7% | 17.3% | ||
| Q3 25 | 1.8% | -67983.3% | ||
| Q2 25 | -12.0% | -396373.3% | ||
| Q1 25 | -1.8% | -383007.1% | ||
| Q4 24 | -17.4% | — | ||
| Q3 24 | -1.1% | -1704400.0% | ||
| Q2 24 | -7.7% | -849120.0% | ||
| Q1 24 | 3.6% | -136200.0% |
| Q4 25 | -8.8% | 22.8% | ||
| Q3 25 | 1.0% | -63195.6% | ||
| Q2 25 | -14.9% | -364386.7% | ||
| Q1 25 | -2.3% | -342657.1% | ||
| Q4 24 | -22.2% | — | ||
| Q3 24 | -1.4% | -1461433.3% | ||
| Q2 24 | -6.7% | -699060.0% | ||
| Q1 24 | 2.6% | -115717.9% |
| Q4 25 | $-0.29 | $0.43 | ||
| Q3 25 | $0.04 | $-1.01 | ||
| Q2 25 | $-0.45 | $-0.98 | ||
| Q1 25 | $-0.17 | $-0.86 | ||
| Q4 24 | $-0.84 | — | ||
| Q3 24 | $-0.06 | $-0.79 | ||
| Q2 24 | $-0.24 | $-0.63 | ||
| Q1 24 | $0.20 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.2M | $402.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $160.6M | $505.7M |
| Total Assets | $468.0M | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $402.7M | ||
| Q3 25 | $5.7M | $305.1M | ||
| Q2 25 | $8.6M | $293.2M | ||
| Q1 25 | $3.3M | $321.4M | ||
| Q4 24 | $9.3M | $424.9M | ||
| Q3 24 | $9.8M | $501.9M | ||
| Q2 24 | $6.8M | $541.9M | ||
| Q1 24 | $32.2M | $525.9M |
| Q4 25 | $160.6M | $505.7M | ||
| Q3 25 | $170.0M | $369.0M | ||
| Q2 25 | $167.9M | $420.9M | ||
| Q1 25 | $182.7M | $469.7M | ||
| Q4 24 | $188.1M | $510.6M | ||
| Q3 24 | $215.7M | $552.9M | ||
| Q2 24 | $218.4M | $588.3M | ||
| Q1 24 | $222.8M | $600.6M |
| Q4 25 | $468.0M | $566.7M | ||
| Q3 25 | $433.8M | $424.0M | ||
| Q2 25 | $463.7M | $473.6M | ||
| Q1 25 | $452.4M | $515.7M | ||
| Q4 24 | $533.1M | $560.4M | ||
| Q3 24 | $488.6M | $604.0M | ||
| Q2 24 | $471.4M | $620.1M | ||
| Q1 24 | $491.2M | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.7M | $28.6M |
| Free Cash FlowOCF − Capex | $-8.9M | $28.5M |
| FCF MarginFCF / Revenue | -7.8% | 33.5% |
| Capex IntensityCapex / Revenue | 2.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $1.7M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.7M | $28.6M | ||
| Q3 25 | $32.0M | $-46.5M | ||
| Q2 25 | $-56.5M | $-43.4M | ||
| Q1 25 | $41.2M | $-47.8M | ||
| Q4 24 | $-41.1M | $-134.6M | ||
| Q3 24 | $16.6M | $-29.4M | ||
| Q2 24 | $-33.7M | $-30.2M | ||
| Q1 24 | $69.7M | $-29.1M |
| Q4 25 | $-8.9M | $28.5M | ||
| Q3 25 | $29.8M | $-46.6M | ||
| Q2 25 | $-57.8M | $-43.4M | ||
| Q1 25 | $38.7M | $-48.4M | ||
| Q4 24 | $-43.7M | $-138.4M | ||
| Q3 24 | $15.0M | $-31.2M | ||
| Q2 24 | $-35.2M | $-30.6M | ||
| Q1 24 | $60.6M | $-29.8M |
| Q4 25 | -7.8% | 33.5% | ||
| Q3 25 | 22.6% | -51765.6% | ||
| Q2 25 | -56.3% | -289620.0% | ||
| Q1 25 | 16.0% | -345635.7% | ||
| Q4 24 | -34.4% | -13837100.0% | ||
| Q3 24 | 10.6% | -1038966.7% | ||
| Q2 24 | -30.2% | -611840.0% | ||
| Q1 24 | 24.7% | -106421.4% |
| Q4 25 | 2.0% | 0.1% | ||
| Q3 25 | 1.7% | 101.1% | ||
| Q2 25 | 1.3% | 440.0% | ||
| Q1 25 | 1.0% | 4507.1% | ||
| Q4 24 | 2.1% | 378600.0% | ||
| Q3 24 | 1.2% | 59266.7% | ||
| Q2 24 | 1.3% | 6980.0% | ||
| Q1 24 | 3.7% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | 25.40× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
FDMT
Segment breakdown not available.
